06). The demographic characteristics of the patients in the confirmation study were comparable to those of the patients in the principal study (Table 1), even though there was a difference in selective digestive tract decontamination, type of intravenous antibiotic prophylaxis, and immunosuppressive therapy. The frequencies Apoptosis Compound Library for the various

SNPs of the recipients were similar compared to the principal group (Supporting Table 2). The cumulative incidence of CSI within the first year was significantly lower (22% [36/167] versus 41% [59/143], P = 0.007) and the percentage of transplanted donor livers with an MBL-deficient genotype was significantly lower in this confirmation group compared to the principal study (13% [22/167] versus 22% [31/143], P = 0.05; Supporting Table 2). Nevertheless, the lectin pathway gene profile of the donor liver in this confirmation group showed a similar significant association with the cumulative incidence of CSI (56% [5/9]

with three variants, 26% [15/57] with two variants, 15% [12/81] with one variant, and 20% [4/20] when genetic variants were absent, Ku 0059436 log-rank = 8.2; P = 0.04). Furthermore, the effect of the donor-recipient genotypic match was also confirmed. MBL mismatch, i.e., a sufficient recipient and an insufficient donor liver, conferred a significantly increased risk for developing clinically significant infection compared to the other MBL combinations (40% [8/20] versus 19% [28/147],

P = 0.03), whereas again a lower risk of CSI was associated with absence of the minor T-allele in FCN2 SNP rs17549193 (10% [5/50] versus 27% [31/117], P < 0.03) and the absence of homozygosity for the major A-allele in MASP2 SNP rs12711521 (9% [2/23] versus 24% [34/144], P = 0.11) in both recipient and donor. In the selleck chemical univariate regression models, a significant association was found for the separate donor gene polymorphisms with CSI of the combined data from both cohorts, in particular for MBL2 (XA/O and O/O) and FCN2 (rs17549193), and less so for MASP2 (rs12711521) (Table 3). In addition, the lectin pathway gene profile of the donor liver showed a significant stepwise association with CSI. In the presence of three variants, 67% CSI was found; 38% CSI was found in the case of two variants, 23% CSI in the case of one variant, and 19% CSI was found when genetic variants in the lectin pathway were absent (P < 0.001). The only other factors associated with the infection risk were found to be male sex of the donor and recipient, the antibiotic prophylactic regimen used, and acute cellular rejection.